For: | Baršić N, Lerotić I, Smirčić-Duvnjak L, Tomašić V, Duvnjak M. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(30): 3945-3954 [PMID: 22912545 DOI: 10.3748/wjg.v18.i30.3945] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i30/3945.htm |
Number | Citing Articles |
1 |
Yan Bi, Sudhakar K. Venkatesh, Vijay H. Shah. Detecting fibrosis without a liver biopsy: getting to the fat of the issue. Hepatology International 2013; 7(3): 792 doi: 10.1007/s12072-013-9450-3
|
2 |
Jing Chen, Yueyong Zhu, Qi Zheng, Jiaji Jiang. Serum cytokeratin‐18 in the diagnosis of non‐alcoholic steatohepatitis: A meta‐analysis. Hepatology Research 2014; 44(8): 854 doi: 10.1111/hepr.12197
|
3 |
Koen D. Reesink, Tim Hendrikx, Patrick J. van Gorp, Arnold P. Hoeks, Ronit Shiri‐Sverdlov. Ultrasonic Perfluorohexane‐Loaded Monocyte Imaging: Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease. Journal of Ultrasound in Medicine 2018; 37(4): 921 doi: 10.1002/jum.14432
|
4 |
Mengyuan Ma, Junying Cheng, Xiaoben Li, Zhuangzhuang Fan, Changqing Wang, Scott B. Reeder, Diego Hernando. Prediction of MRI R2*$$ {\mathrm{R}}_2^{\ast } $$ relaxometry in the presence of hepatic steatosis by Monte Carlo simulations. NMR in Biomedicine 2024; doi: 10.1002/nbm.5274
|
5 |
Muammer Kara, Teoman Dogru, Halil Genc, Erdim Sertoglu, Gurkan Celebi, Hasan Gurel, Hüseyin Kayadibi, Ali F. Cicek, Cemal N. Ercin, Alper Sonmez. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(10): 1144 doi: 10.1097/MEG.0000000000000405
|
6 |
Patrick H. Alizai, Isabella Lurje, Andreas Kroh, Sophia Schmitz, Tom Luedde, Julia Andruszkow, Ulf P. Neumann, Florian Ulmer. Noninvasive Evaluation of Liver Function in Morbidly Obese Patients. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/4307462
|
7 |
Patrick H. Alizai, Janica Wendl, Anjali A. Roeth, Christian D. Klink, Tom Luedde, Inga Steinhoff, Ulf P. Neumann, Maximilian Schmeding, Florian Ulmer. Functional Liver Recovery After Bariatric Surgery—a Prospective Cohort Study with the LiMAx Test. Obesity Surgery 2015; 25(11): 2047 doi: 10.1007/s11695-015-1664-0
|
8 |
Carmen Fierbinteanu Braticevici, Ioan Sporea, Eugenia Panaitescu, Laura Tribus. Value of Acoustic Radiation Force Impulse Imaging Elastography for Non-invasive Evaluation of Patients with Nonalcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2013; 39(11): 1942 doi: 10.1016/j.ultrasmedbio.2013.04.019
|
9 |
Tomislav Bulum, Branko Kolarić, Marko Duvnjak, Lea Duvnjak. Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients. Renal Failure 2014; 36(3): 372 doi: 10.3109/0886022X.2013.872569
|
10 |
Dhananjay Yadav, Eunhee Choi, Song Vogue Ahn, Sang Baek Koh, Ki-Chul Sung, Jang-Young Kim, Ji Hye Huh. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study. Medicine 2016; 95(31): e4447 doi: 10.1097/MD.0000000000004447
|
11 |
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818811508
|
12 |
José Illnait, Iván Rodríguez, Sarahí Mendoza, Yolanda Fernández, Rosa Mas, Mirtha Miranda, Jesús Piñera, Julio César Fernández, Meilis Mesa, Lilia Fernández, Daisy Carbajal, Rafael Gámez. Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. The Korean Journal of Internal Medicine 2013; 28(4): 439 doi: 10.3904/kjim.2013.28.4.439
|
13 |
Joseph M. Pappachan, Farrah A. Antonio, Mahamood Edavalath, Arjun Mukherjee. Non-alcoholic fatty liver disease: a diabetologist’s perspective. Endocrine 2014; 45(3): 344 doi: 10.1007/s12020-013-0087-8
|
14 |
Young Eun Chon, Kyu Sik Jung, Kwang Joon Kim, Dong Jin Joo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim. Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in Korea. Digestive Diseases and Sciences 2015; 60(1): 234 doi: 10.1007/s10620-014-3293-1
|
15 |
E. García-Escobar, S. Valdés, F. Soriguer, J. Vendrell, I. M. Urrutia-Etxebarria, C. Maldonado-Araque, E. Ortega, P. Ocón, E. Montanya, E. Menéndez, A. Lago-Sampedro, T. González-Frutos, R. Gomis, A. Goday, S. García-Serrano, J. L. Galán-García, C. Castell, E. Bordiú, R. Badía, G. Aguilera-Venegas, J. Girbés, S. Gaztambide, E. Delgado, F. J. Chaves, L. Castaño, A. Calle-Pascual, G. Rojo-Martínez, J. Franch-Nadal. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95546-x
|
16 |
Steven J. Potts, Johanna K. DiStefano. Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Methods in Pharmacology and Toxicology 2014; : 101 doi: 10.1007/7653_2014_29
|
17 |
Prasad P. Torkadi, I. C. Apte, A. K. Bhute. Biochemical Evaluation of Patients of Alcoholic Liver Disease and Non-alcoholic Liver Disease. Indian Journal of Clinical Biochemistry 2014; 29(1): 79 doi: 10.1007/s12291-013-0310-7
|
18 |
Shubha Lal. Non Alcoholic Steatohepatitis. Advances in Cytology & Pathology 2017; 2(3) doi: 10.15406/acp.2017.02.00022
|
19 |
Lauren Pavlik, Arie Regev, Paul A. Ardayfio, Naga P. Chalasani. Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Drug Safety 2019; 42(6): 701 doi: 10.1007/s40264-018-00790-2
|
20 |
David E. Amacher. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014; 19(7): 541 doi: 10.3109/1354750X.2014.958535
|
21 |
Iben M. Miller, Astrid Vindsand Naver, Ulla B. Mogensen, Kian Zarchi, Hans C. Ring, Christina Ellervik, Gregor B.E. Jemec. Gallstones are associated with hidradenitis suppurativa. European Journal of Gastroenterology & Hepatology 2015; 27(12): 1392 doi: 10.1097/MEG.0000000000000469
|
22 |
Lise L Gluud, Filip K Knop, Tina Vilsbøll. Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes. BMJ Open 2014; 4(12): e005325 doi: 10.1136/bmjopen-2014-005325
|
23 |
Siham N.K. Al-Shaaibi, Mostafa I. Waly, Lyutha Al-Subhi, Mohamed H. Tageldin, Nada M. Al-Balushi, Mohammad Shafiur Rahman. Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats. Preventive Nutrition and Food Science 2016; 21(1): 14 doi: 10.3746/pnf.2016.21.1.14
|
24 |
S.A. Townsend, Philip N. Newsome. Non-alcoholic fatty liver disease in 2016. British Medical Bulletin 2016; 119(1): 143 doi: 10.1093/bmb/ldw031
|
25 |
Kay M. Pepin, Christopher L. Welle, Flavius F. Guglielmo, Jonathan R. Dillman, Sudhakar K. Venkatesh. Magnetic resonance elastography of the liver: everything you need to know to get started. Abdominal Radiology 2022; 47(1): 94 doi: 10.1007/s00261-021-03324-0
|
26 |
Ravirajsinh N. Jadeja, Ranjitsinh V. Devkar. Polyphenols in Human Health and Disease. 2014; : 615 doi: 10.1016/B978-0-12-398456-2.00047-5
|
27 |
Iria Cebreiros López, José Antonio Noguera Velasco. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínico. Revista del Laboratorio Clínico 2018; 11(3): 163 doi: 10.1016/j.labcli.2017.10.004
|
28 |
Ji Hye Huh, Jang Young Kim, Eunhee Choi, Jae Seok Kim, Yoosoo Chang, Ki-Chul Sung, Tatsuo Shimosawa. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. PLOS ONE 2017; 12(7): e0180951 doi: 10.1371/journal.pone.0180951
|
29 |
Mee Kyoung Kim. Biomarkers of Disease Severity in Nonalcoholic Fatty Liver Disease. The Korean Journal of Obesity 2013; 22(2): 83 doi: 10.7570/kjo.2013.22.2.83
|
30 |
Z. M. Younossi, M. J. Reyes, A. Mishra, R. Mehta, L. Henry. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Alimentary Pharmacology & Therapeutics 2014; 39(1): 3 doi: 10.1111/apt.12543
|
31 |
Roberta Maggio, Carmela Viscomi, Paola Andreozzi, Gabriella D'Ettorre, Giovanni Viscogliosi, Barbara Barbaro, Manuele Gori, Vincenzo Vullo, Clara Balsano, Salvatore Petta. Normocaloric Low Cholesterol Diet Modulates Th17/Treg Balance in Patients with Chronic Hepatitis C Virus Infection. PLoS ONE 2014; 9(12): e112346 doi: 10.1371/journal.pone.0112346
|
32 |
Gesine Meyer, Nina Dauth, Matthias Grimm, Eva Herrmann, Joerg Bojunga, Mireen Friedrich-Rust. Shear Wave Elastography Reveals a High Prevalence of NAFLD-related
Fibrosis even in Type 1 Diabetes. Experimental and Clinical Endocrinology & Diabetes 2022; 130(08): 532 doi: 10.1055/a-1666-0431
|
33 |
Naoya Otsubo, Tatsuya Fukuda, Genhin Cho, Fumiaki Ishibashi, Tetsuya Yamada, Koshiro Monzen. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People. Internal Medicine 2023; 62(16): 2307 doi: 10.2169/internalmedicine.1097-22
|
34 |
Ali A. Weinstein, Dung Ngo, Leyla de Avila, Jillian K. Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn H. Gerber, Zobair M. Younossi. Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease. Annals of Medicine 2023; 55(1): 1345 doi: 10.1080/07853890.2023.2193422
|
35 |
Yousef Fazel, Aaron B. Koenig, Mehmet Sayiner, Zachary D. Goodman, Zobair M. Younossi. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016; 65(8): 1017 doi: 10.1016/j.metabol.2016.01.012
|
36 |
Goh Eun Chung, Donghee Kim. Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis. Clinical and Molecular Hepatology 2013; 19(2): 116 doi: 10.3350/cmh.2013.19.2.116
|
37 |
Anthony Petrick, Peter Benotti, G. Craig Wood, Christopher D. Still, William E. Strodel, John Gabrielsen, David Rolston, Xin Chu, George Argyropoulos, Anna Ibele, Glenn S. Gerhard. Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients. Obesity Surgery 2015; 25(12): 2368 doi: 10.1007/s11695-015-1707-6
|
38 |
|
39 |
Sabine Kahl, Klaus Straßburger, Bettina Nowotny, Roshan Livingstone, Birgit Klüppelholz, Kathrin Keßel, Jong-Hee Hwang, Guido Giani, Barbara Hoffmann, Giovanni Pacini, Amalia Gastaldelli, Michael Roden, Michael Müller. Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance. PLoS ONE 2014; 9(4): e94059 doi: 10.1371/journal.pone.0094059
|
40 |
Oguzhan Ozturk, Yasar Colak, Ebubekir Senates, Yusuf Yilmaz, Celal Ulasoglu, Levent Doganay, Seyma Ozkanli, Yasemin Musteri Oltulu, Ender Coskunpinar, Ilyas Tuncer. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(26): 8096-8102 doi: 10.3748/wjg.v21.i26.8096
|
41 |
Muhammad Imran, Odile Sergent, Arnaud Tête, Isabelle Gallais, Martine Chevanne, Dominique Lagadic-Gossmann, Normand Podechard. Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae. Biomolecules 2018; 8(2): 26 doi: 10.3390/biom8020026
|
42 |
Mesbah Uddin Ahmed. Association of Serum Cytokeratin-18 Fragment Concentration in Patients with Different Types of Nonalcoholic Fatty Liver Disease. Gastroenterology & Hepatology : Open Access 2015; 2(2) doi: 10.15406/ghoa.2015.02.00037
|
43 |
Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, Mingchun Zhong, Yang Zou. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01479-9
|
44 |
M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver disease. Journal of Clinical and Scientific Research 2015; 4(1): 31 doi: 10.15380/2277-5706.JCSR.14.072
|
45 |
Yali Le, Yue Chen, Zhanwen Huang, Liang Cai, Li Zhang. Intense FDG Activity in Focal Hepatic Steatosis. Clinical Nuclear Medicine 2014; 39(7): 669 doi: 10.1097/RLU.0000000000000472
|
46 |
Utsav Shrestha, Marie van der Merwe, Nirman Kumar, Eddie Jacobs, Sanjaya K. Satapathy, Cara Morin, Aaryani Tipirneni‐Sajja. Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity. NMR in Biomedicine 2021; 34(6) doi: 10.1002/nbm.4489
|
47 |
Naile Bolca Topal, Serap Orcan, Deniz Sığırlı, Gökhan Orcan, Ülkü Eritmen. Effects of fat accumulation in the liver on hemodynamic variables assessed by doppler ultrasonography. Journal of Clinical Ultrasound 2015; 43(1): 26 doi: 10.1002/jcu.22157
|
48 |
Jong Wook Choi, Il Hwan Oh, Chang Hwa Lee, Joon-Sung Park. Is there a J-shaped relationship between the fatty liver index and risk of microalbuminuria in the general population?. Clinica Chimica Acta 2018; 481: 231 doi: 10.1016/j.cca.2017.08.015
|
49 |
Hyun Jung Koo, SungRyul Lee, Kwang Jin Chang, Eunsoo Sohn, Eun-Hwa Sohn, Se Chan Kang, Suhkneung Pyo. Hepatic anti-inflammatory effect of hexane extracts of Dioscorea batatas Decne: Possible suppression of toll-like receptor 4-mediated signaling. Biomedicine & Pharmacotherapy 2017; 92: 157 doi: 10.1016/j.biopha.2017.05.036
|
50 |
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Expert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
|